Unlocking innovative medicines
Our mission is to create a global biopharma drug discovery powerhouse with an asset-rich portfolio of small molecule drugs across a range of disease areas, by unlocking innovative medicines for otherwise untreatable conditions.
We have a drug discovery pipeline of in-house projects and ongoing partnerships. We work across a range of disease areas where drug specificity is a significant challenge, such as cancer and neurological disease.
In particular, we specialize in drugging challenging targets, for example using our technology to tackle specific protein-protein interactions of major cancer targets.